Vote for your favorite mineral in #MinCup25! - Cuprosklodowskite vs. Ikaite
It's radioactive #cuprosklodowskite vs ephemeral #ikaite for today's match.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

Khan, Huzaifa Yasir, Tabassum, Sartaj, Arjmand, Farukh (2020) Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines. RSC Advances, 10 (1). 166-178 doi:10.1039/c9ra07464c

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleEvaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines
JournalRSC Advances
AuthorsKhan, Huzaifa YasirAuthor
Tabassum, SartajAuthor
Arjmand, FarukhAuthor
Year2020Volume10
Issue1
PublisherRoyal Society of Chemistry (RSC)
DOIdoi:10.1039/c9ra07464cSearch in ResearchGate
Generate Citation Formats
Mindat Ref. ID8133099Long-form Identifiermindat:1:5:8133099:5
GUID0
Full ReferenceKhan, Huzaifa Yasir, Tabassum, Sartaj, Arjmand, Farukh (2020) Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines. RSC Advances, 10 (1). 166-178 doi:10.1039/c9ra07464c
Plain TextKhan, Huzaifa Yasir, Tabassum, Sartaj, Arjmand, Farukh (2020) Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines. RSC Advances, 10 (1). 166-178 doi:10.1039/c9ra07464c
In(2020) RSC Advances Vol. 10 (1) Royal Society of Chemistry (RSC)

See Also

These are possibly similar items as determined by title/reference text matching only.

Yasir Khan, Huzaifa, Tabassum, Sartaj, Arjmand, Farukh (2023) Preparation and characterization of ionic metal-based anticancer formulations of the type [bis-DACH tolfenamate metal {Co(II), Cu(II) and Zn(II)}] complexes: Binding studies with ct-DNA/tRNA, cleavage and cytotoxic activity against chemoresistant cancer cells. Inorganica Chimica Acta, 558. 121725 doi:10.1016/j.ica.2023.121725
Khursheed, Salman, Tabassum, Sartaj, Arjmand, Farukh (2022) Comprehensive biological {DNA/RNA binding profile, cleavage &cytotoxicity activity} of structurally well-characterized chromone-appended Cu(II)(L1-3)(phen) potential anticancer drug candidates. Polyhedron, 214. 115638 doi:10.1016/j.poly.2021.115638
Parveen, Sabiha, Jafri, Saman, Yasir Khan, Huzaifa, Tabassum, Sartaj, Arjmand, Farukh (2021) Elucidating the interaction of enantiomeric Cu(II) complexes with DNA, RNA and HSA: A comparative study. Polyhedron, 210. 115501 doi:10.1016/j.poly.2021.115501
Zehra, Siffeen, Gómez-Ruiz, Santiago, Siddique, Hifzur R., Tabassum, Sartaj, Arjmand, Farukh (2020) Water soluble ionic Co(ii), Cu(ii) and Zn(ii) diimine–glycinate complexes targeted to tRNA: structural description, in vitro comparative binding, cleavage and cytotoxic studies towards chemoresistant prostate cancer cells. Dalton Transactions, 49 (46) 16830-16848 doi:10.1039/d0dt02657c
Rijwan, , Arjmand, Farukh, Tabassum, Sartaj (2024) Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(ii), Cu(ii) and Zn(ii)] tailored anticancer chemotherapeutic agents against resistant cancer cells. Dalton Transactions, 53 (24) 10126-10141 doi:10.1039/d4dt00426d
Yousuf, Imtiyaz, Arjmand, Farukh, Tabassum, Sartaj, Toupet, Loic, Khan, Rais Ahmad, Siddiqui, Maqsood Ahmad (2015) Mechanistic insights into a novel chromone-appended Cu(ii) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells. Dalton Transactions, 44 (22). 10330-10342 doi:10.1039/c5dt00770d
Parveen, Sabiha, Tabassum, Sartaj, Arjmand, Farukh (2017) Synthesis of chiral R/S-pseudopeptide-based Cu(ii) & Zn(ii) complexes for use in targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA and pBR322 DNA hydrolytic cleavage mechanism. RSC Advances, 7 (11). 6587-6597 doi:10.1039/c6ra24770a
Rijwan, , Arjmand, Farukh, Tabassum, Sartaj (2025) Synthesis, spectroscopic, single crystal X-ray diffraction studies of Bilastine, BLA(bpy)2Cu(II) & Zn(II) complexes as anticancer chemotherapeutic agents: Validation of their cytotoxic potency on cancer cell lines. Journal of Molecular Structure, 1328. doi:10.1016/j.molstruc.2024.141244
Bashir, Masrat, Yousuf, Imtiyaz, Ahmad, Mushtaq, Arjmand, Farukh, Tabassum, Sartaj (2023) Synthesis, structural characterization and in vitro cytotoxicity assessment of new mononuclear Cu(II) and Co(II) complexes against MDA–MB–231, HCC–1806 and HT–29 cancer cell lines. Polyhedron, 229. 116189 doi:10.1016/j.poly.2022.116189
Usman, Mohammad, Tabassum, Sartaj, Arjmand, Farukh, Khan, Rais Ahmad, Ali, Mohd. Sajid, Al-Lohedan, Hamad A., Alsalme, Ali, Farah, Mohammad Abul, Al-Anazi, Khalid Mashay, Ahmad, Musheer (2018) Cu II -Na I heteronuclear complex as anticancer entity against human breast cancer cell lines: DNA binding, cleavage, and Computational studies. Inorganica Chimica Acta, 479. 229-239 doi:10.1016/j.ica.2018.04.036
Ansari, Mohammad Fawad; Arjmand, Farukh (2025) Synthesis of mefenamate-diamine metallo-drugs {Ni(II), Cu(II), Zn(II)} anticancer drug formulation: Validation of in vitro binding and cytotoxic profile against cancer {HeLa, Hep-G2, MDA-MB-231 and MIA-PA-CA-2} cell lines. Journal of Molecular Structure, 1338. doi:10.1016/j.molstruc.2025.142269
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 14, 2025 09:15:12
Go to top of page